Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s12094-017-1657-7
Published Online: 2017-04-13
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aparicio, L. M. A.
Fernandez, I. P.
Cassinello, J.
License valid from 2017-04-13